Stock comparison
LeMaitre Vascular
Teleflex
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LMAT
LeMaitre Vascular
Market cap
$2.32B
Sector
Healthcare
TFX
Teleflex
Market cap
$5.74B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LMAT | TFX | Winner |
|---|---|---|---|
| Warren Buffett | 77B | 27F | LMAT |
| Benjamin Graham | 89A | 35D | LMAT |
| Philip Fisher | 81C | 31F | LMAT |
| Peter Lynch | 67B | 1F | LMAT |
| Joel Greenblatt | 56D | 27F | LMAT |
| Charlie Munger | 68D | 23F | LMAT |
| Terry Smith | 69D | 19F | LMAT |
Side-by-side metrics
| Metric | LMAT | TFX |
|---|---|---|
| Market cap | $2.32B | $5.74B |
| P/E (TTM) | 37.1x | - |
| EV/EBIT | 36.6x | 21.9x |
| ROIC (TTM) | 9.43% | 2.73% |
| Gross margin | 72.39% | 53.27% |
| Net margin | 24.35% | -35.89% |
| Revenue CAGR 5y | 12.75% | -8.23% |
| EPS CAGR 5y | 19.04% | - |
| Debt / Equity | 0.5x | 0.1x |
| Dividend yield | 0.84% | 1.05% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LMAT leads on
- Net margin24.35%vs -35.89%+168%
- Revenue CAGR 5y12.75%vs -8.23%+165%
- ROIC (TTM)9.43%vs 2.73%+71%
- Gross margin72.39%vs 53.27%+26%
TFX leads on
- P/E (TTM)-vs 37.1x+115%
- Debt / Equity0.1xvs 0.5x+88%
- Market cap$5.74Bvs $2.32B+60%
- EV/EBIT21.9xvs 36.6x+40%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.